Drugs / PRP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03602950 Comparator | Aug 2018 → Feb 2019 | gestational diabetes | Minia University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03602950 ↗ |
| Route | Subcutaneous | “autologous PRP will be injected subcutaneously before skin closure at time of elective CS” NCT03602950 ↗ |